Home > Insider Trading > Filing (0001683168-20-000786)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1226616	Medicinova Inc	MNOV	Pharmaceutical Preparations (2834)	330927979

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263965	Yuichi Iwaki	C/O Medicinova, Inc. 4275 Executive Square, Suite 300 La Jolla CA 92037	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-12	20,000	$3.10	780,683	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	125,000	Indirect	See Footnote

Footnotes

The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price at price ranging from $3.055 to $3.14. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Includes 1,291shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
The reported securities are held by the Iwaki Family Limited Partnership. The reporting person is the general partner of the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.